- Home
- CELC vs NFGC Comparison
CELC vs NFGC Comparison
Compare CELC & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- NFGC
- Stock Information
- Founded
- CELC 2011
- NFGC 2016
- Country
- CELC United States
- NFGC Canada
- Employees
- CELC N/A
- NFGC N/A
- Industry
- CELC Medical Specialities
- NFGC Precious Metals
- Sector
- CELC Health Care
- NFGC Basic Materials
- Exchange
- CELC Nasdaq
- NFGC Nasdaq
- Market Cap
- CELC 327.3M
- NFGC 226.7M
- IPO Year
- CELC 2017
- NFGC N/A
- Fundamental
- Price
- CELC $10.53
- NFGC $1.26
- Analyst Decision
- CELC Strong Buy
- NFGC Strong Buy
- Analyst Count
- CELC 6
- NFGC 1
- Target Price
- CELC $30.17
- NFGC $5.00
- AVG Volume (30 Days)
- CELC 195.9K
- NFGC 750.6K
- Earning Date
- CELC 05-14-2025
- NFGC 05-16-2025
- Dividend Yield
- CELC N/A
- NFGC N/A
- EPS Growth
- CELC N/A
- NFGC N/A
- EPS
- CELC N/A
- NFGC N/A
- Revenue
- CELC N/A
- NFGC N/A
- Revenue This Year
- CELC N/A
- NFGC N/A
- Revenue Next Year
- CELC N/A
- NFGC N/A
- P/E Ratio
- CELC N/A
- NFGC N/A
- Revenue Growth
- CELC N/A
- NFGC N/A
- 52 Week Low
- CELC $7.58
- NFGC $0.93
- 52 Week High
- CELC $19.77
- NFGC $4.07
- Technical
- Relative Strength Index (RSI)
- CELC 51.41
- NFGC 53.91
- Support Level
- CELC $9.64
- NFGC $1.07
- Resistance Level
- CELC $11.66
- NFGC $1.22
- Average True Range (ATR)
- CELC 0.66
- NFGC 0.07
- MACD
- CELC -0.04
- NFGC 0.03
- Stochastic Oscillator
- CELC 44.06
- NFGC 97.43
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About NFGC New Found Gold Corp
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).